Ossining, NY, United States of America

Christopher Cowan


Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovative Contributions of Christopher Cowan

Introduction

Christopher Cowan, a distinguished inventor based in Ossining, NY, has made significant strides in the field of protein purification with his innovative patent. Known for his insightful contributions to biotechnology, Cowan's work exemplifies the intersection of cutting-edge technology and practical application in pharmaceuticals.

Latest Patents

Cowan holds a patent titled "Use of Raman spectroscopy in downstream purification." This patent introduces in situ Raman spectroscopy methods and systems designed for characterizing and quantifying protein purification intermediates during production. The methodology holds great potential for ensuring the quality of the final drug products by allowing real-time analysis during the purification process, significantly enhancing the efficacy and safety of pharmaceutical manufacturing.

Career Highlights

Christopher Cowan proudly serves as a pivotal contributor at Regeneron Pharmaceuticals, Inc., a reputable company known for its commitment to innovative drug discovery and development. His experience and expertise have positioned him as a vital asset in tackling complex challenges within the pharmaceutical realm.

Collaborations

Throughout his career, Cowan has collaborated with talented colleagues such as Christina Passno and Andrew Tustian. These partnerships have fostered an environment of creativity and innovation, driving advancements in protein purification methodologies that are crucial for the development of high-quality therapeutic products.

Conclusion

In summary, Christopher Cowan’s contributions to the field of protein purification through his patent on Raman spectroscopy highlight the importance of innovation in the pharmaceutical industry. His work at Regeneron Pharmaceuticals and collaborations with fellow researchers underscore a commitment to improving the manufacturing processes that are essential for developing effective medications, ultimately benefiting patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…